経皮的血管形成術（PTA）の世界市場（2024年版）：製品タイプ別、用途別、エンドユーザー別、地域別の分析、市場考察、予測（2020年～2030年）

世界の経皮的血管形成術（PTA）の市場規模は、2020年～2023年にCAGRで10.25%で成長を示しました。市場規模は2023年に29億2,000万米ドルであり、2030年に69億5,000万米ドルに達すると予測されています。市場は、心血管疾患の有病率の上昇、技術の進歩、高齢化、意識の高まり、医療インフラの向上、有利な償還政策、低侵襲手技の採用の増加、医療費の上昇、メディカルツーリズム、戦略的な産業連携などによって牽引されています。

World Heart Federationによると、現在も世界中で5億人以上の人々が心血管疾患に罹患しており、2021年の死亡者数は2,050万人で、世界全体の死亡者数の3分の1近くを占め、CVDによる死亡者数は1億2,100万人と推定されます。冠動脈疾患、末梢動脈疾患、不整脈を含む心血管疾患は、引き続き世界の罹患率と死亡率の主因となっています。このような心血管疾患の急増は、大きな手術を必要とせずに閉塞または狭窄した動脈の血流を回復させるPTAのような効果的で低侵襲な治療オプションに対する大きな需要を生み出しています。

低侵襲の選択肢に対する認識の高まりは、PTAのような手技に対する患者の需要の増加につながっています。痛みや瘢痕、回復時間の短縮といった利点があるため、患者はしばしば低侵襲手技を選好します。また、医療提供者は、CVDの管理における標準的な診療として、PTAのような低侵襲技術を採用するようになってきています。医療技術や手技の進歩により、PTA手技はより安全で効果的、かつ容易に実施できるようになり、臨床医の間で受け入れられつつあります。

薬剤コーティングバルーン（DCB）技術は、経皮的血管形成術（PTA）用バルーンカテーテルの大きな進歩です。これらのバルーンにはパクリタキセルやシロリムスなどの抗増殖薬がコーティングされており、膨張時に動脈壁に局所的に放出されます。この標的化ドラッグデリバリーにより、平滑筋細胞の増殖が抑制され、新生内膜の過形成が抑制されるため、従来の非コーティングバルーンに比べ、血管の長期開存性が改善されます。DCBは、特に複雑な病変や細い血管において、再狭窄率を低下させ、介入を繰り返す必要性を減少させる有効性が実証されています。この技術は、血管形成術に伴う主な課題の1つである再狭窄に対処することによって、PTA手技の転帰を向上させる有望なアプローチです。

血管内超音波（IVUS）や光干渉断層計（OCT）のような先進のイメージング機器は、末梢動脈疾患（PAD）の治療を強化する上で重要な役割を果たしています。IVUSとOCTは末梢動脈の高解像度画像を提供し、正確な病変の評価と治療計画を可能にします。PTA手技中にリアルタイムのガイダンスを提供することで、IVUSとOCTはバルーンサイジング、ステント留置、拡張後の手技の最適化に役立ち、PAD患者の手技転帰の向上と合併症の罹患率の低下につながります。この機能はPAD治療における大きな進歩であり、世界のPTA市場において、手技の精度と患者ケアを向上させる価値あるツールを臨床医にもたらしています。

精密医療と個別化治療の進歩は、遺伝的素因、疾患の表現型、反応プロファイルなどの、個々の患者の特性に合わせたPTA治療を目指すものです。バイオマーカー誘導介入、患者固有の治療アルゴリズム、標的化ドラッグデリバリーシステムは、PTA手技における治療転帰を最適化し、有害事象を最小化する機会を提供します。

当レポートでは、世界の経皮的血管形成術（PTA）市場について調査し、市場規模と予測、地域とセグメントの分析、主要動向と機会などの情報を提供しています。

目次

第1章 市場背景

• 範囲と製品の見通し
• エグゼクティブサマリー
• 調査手法

第2章 戦略的推奨

• 併用療法の有効性の調査
• 発展途上国における低コストの治療法の普及の拡大

第3章 世界の経皮的血管形成術（PTA）市場：実績と予測

• 世界の経皮的血管形成術（PTA）市場に対するマクロ経済要因の影響の分析
• 疫学：世界の慢性疾患の有病率
• 疫学：世界の慢性疾患の罹患率
• 世界の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
• 経皮的血管形成術（PTA）市場に対するCOVID-19の影響度
• 世界の経皮的血管形成術（PTA）市場セグメンテーション：製品タイプ別
  • 世界の経皮的血管形成術（PTA）市場：製品タイプ別、概要
  • 世界の経皮的血管形成術（PTA）市場の魅力指数：製品タイプ別、概要
  • 世界の経皮的血管形成術（PTA）の市場規模：バルーンカテーテル（金額）（2020年～2030年）
  • 世界の経皮的血管形成術（PTA）の市場規模：ステント（金額）（2020年～2030年）
  • 世界の経皮的血管形成術（PTA）の市場規模：ガイドワイヤー（金額）（2020年～2030年）
  • 世界の経皮的血管形成術（PTA）の市場規模：その他（金額）（2020年～2030年）
• 世界の経皮的血管形成術（PTA）市場セグメンテーション：用途別
  • 世界の経皮的血管形成術（PTA）市場：用途別、概要
  • 世界の経皮的血管形成術（PTA）市場の魅力指数：用途別、概要
  • 世界の経皮的血管形成術（PTA）の市場規模：冠動脈疾患（金額）（2020年～2030年）
  • 世界の経皮的血管形成術（PTA）の市場規模：末梢動脈疾患（金額）（2020年～2030年）
• 世界の経皮的血管形成術（PTA）市場セグメンテーション：エンドユーザー別
  • 世界の経皮的血管形成術（PTA）市場の概要：エンドユーザー別
  • 世界の経皮的血管形成術（PTA）市場の魅力指数：エンドユーザー別、概要
  • 世界の経皮的血管形成術（PTA）の市場規模：病院（金額）（2020年～2030年）
  • 世界の経皮的血管形成術（PTA）の市場規模：外来手術センター（金額）（2020年～2030年）
  • 世界の経皮的血管形成術（PTA）の市場規模：専門クリニック（金額）（2020年～2030年）

第4章 世界の経皮的血管形成術（PTA）市場、地域分析

• 調査の地域範囲
• 地域のスナップショット

第5章 南北アメリカの経皮的血管形成術（PTA）市場：実績と予測

• 南北アメリカの経皮的血管形成術（PTA）市場：概要
• 南北アメリカの経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
• 南北アメリカの経皮的血管形成術（PTA）市場：主な要因
• 南北アメリカの経皮的血管形成術（PTA）市場：セグメント分析
• 南北アメリカの経皮的血管形成術（PTA）市場セグメンテーション：製品タイプ別
• 南北アメリカの経皮的血管形成術（PTA）市場セグメンテーション：用途別
• 南北アメリカの経皮的血管形成術（PTA）市場セグメンテーション：エンドユーザー別
• 南北アメリカの経皮的血管形成術（PTA）市場セグメンテーション：国別
  • 欧州の経皮的血管形成術（PTA）市場：国別、概要
  • 米国の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • カナダの経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • その他の南北アメリカの経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）

第6章 欧州の経皮的血管形成術（PTA）市場：実績と予測

• 欧州の経皮的血管形成術（PTA）市場：スナップショット
• 欧州の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
• 欧州の経皮的血管形成術（PTA）市場：主な要因
• 欧州の経皮的血管形成術（PTA）市場：セグメント分析
• 欧州の経皮的血管形成術（PTA）市場セグメンテーション：製品タイプ別
• 欧州の経皮的血管形成術（PTA）市場セグメンテーション：用途別
• 欧州の経皮的血管形成術（PTA）市場セグメンテーション：エンドユーザー別
• 欧州の経皮的血管形成術（PTA）市場セグメンテーション：国別
  • 欧州の経皮的血管形成術（PTA）市場：国別、概要
  • 英国の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • ドイツの経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • フランスの経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • スペインの経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • その他の欧州の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）

第7章 アジア太平洋の経皮的血管形成術（PTA）市場：実績と予測

• アジア太平洋の経皮的血管形成術（PTA）市場：スナップショット
• アジア太平洋の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
• アジア太平洋の経皮的血管形成術（PTA）市場：主な要因
• アジア太平洋の経皮的血管形成術（PTA）市場：セグメント分析
• アジア太平洋の経皮的血管形成術（PTA）市場セグメンテーション：製品タイプ別
• アジア太平洋の経皮的血管形成術（PTA）市場セグメンテーション：用途別
• アジア太平洋の経皮的血管形成術（PTA）市場セグメンテーション：エンドユーザー別
• アジア太平洋の経皮的血管形成術（PTA）市場セグメンテーション：国別
  • アジア太平洋の経皮的血管形成術（PTA）市場：国別、概要
  • 中国の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • 日本の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • インドの経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • 韓国の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
  • その他のアジア太平洋の経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）

第8章 中東・アフリカの経皮的血管形成術（PTA）市場：実績と予測

• 中東・アフリカの経皮的血管形成術（PTA）市場：スナップショット
• 中東・アフリカの経皮的血管形成術（PTA）市場：市場規模とCAGR（2020年～2030年）
• 中東・アフリカの経皮的血管形成術（PTA）市場：主な要因
• 中東・アフリカの経皮的血管形成術（PTA）市場：セグメント分析
• 中東・アフリカの経皮的血管形成術（PTA）市場セグメンテーション：製品タイプ別
• 中東・アフリカの経皮的血管形成術（PTA）市場セグメンテーション：用途別
• 中東・アフリカの経皮的血管形成術（PTA）市場セグメンテーション：エンドユーザー別

第9章 市場力学

• 世界の経皮的血管形成術（PTA）市場に対する市場力学の影響の評価
• 促進要因
• 抑制要因
• 動向

第10章 産業エコシステム分析

• ポーター分析

第11章 競合ポジショニング

• 企業の製品ポジショニング
• 主要企業の市場シェア
• 企業プロファイル
  • Medtronic PLC
  • Terumo Corporation
  • Cardinal Health, Inc
  • Boston Scientific
  • Teleflex Incorporated
  • Johnson & Johnson
  • Abbott Laboratories
  • Stryker Corporation
  • Becton Dickinson and Co
  • Cook Group Inc.

第12章 当社について、免責事項

List of Figures

• Figure 1: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020-2023 (USD Million)
• Figure 2: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2024-2030 (USD Million)
• Figure 3: Global Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
• Figure 4: Market Attractiveness Analysis of Global Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type (2025-2030)
• Figure 5: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 6: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 7: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 8: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Stents, 2020H-2030F (USD Million)
• Figure 9: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 10: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Guidewires, 2020H-2030F (USD Million)
• Figure 11: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 12: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Others, 2020H-2030F (USD Million)
• Figure 13: Market Attractiveness Analysis of Global Percutaneous Transluminal Angioplasty (PTA) Market, By Application (2025-2030)
• Figure 14: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 15: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Coronary Artery Disease, 2020H-2030F (USD Million)
• Figure 16: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 17: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Peripheral Artery Disease, 2020H-2030F (USD Million)
• Figure 18: Market Attractiveness Analysis of Global Percutaneous Transluminal Angioplasty (PTA) Market, By End User (2025-2030)
• Figure 19: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 20: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Hospitals, 2020H-2030F (USD Million)
• Figure 21: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 22: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Ambulatory Surgical Centers, 2020H-2030F (USD Million)
• Figure 23: Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 24: Global Percutaneous Transluminal Angioplasty (PTA) Market Absolute Opportunity, By Specialty Clinics, 2020H-2030F (USD Million)
• Figure 25: Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020H-2030F (USD Million)
• Figure 26: Americas Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
• Figure 27: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 28: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 29: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 30: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 31: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 32: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 33: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 34: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 35: Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 36: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 37: United States Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 38: United States Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 39: United States Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 40: United States Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 41: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 42: Canada Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 43: Canada Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 44: Canada Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 45: Canada Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 46: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 47: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 48: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 49: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 50: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 51: Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020H-2030F (USD Million)
• Figure 52: Europe Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
• Figure 53: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 54: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 55: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 56: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 57: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 58: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 59: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 60: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 61: Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 62: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 63: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 64: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 65: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 66: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 67: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 68: Germany Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 69: Germany Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 70: Germany Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 71: Germany Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 72: France Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 73: France Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 74: France Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 75: France Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 76: France Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 77: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 78: Spain Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 79: Spain Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 80: Spain Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 81: Spain Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 82: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 83: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 84: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 85: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 86: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 87: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020H-2030F (USD Million)
• Figure 88: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
• Figure 89: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 90: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 91: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 92: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 93: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 94: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 95: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 96: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 97: Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 98: China Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 99: China Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 100: China Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 101: China Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 102: China Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 103: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 104: Japan Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 105: Japan Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 106: Japan Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 107: Japan Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 108: India Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 109: India Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 110: India Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 111: India Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 112: India Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 113: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 114: South Korea Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 115: South Korea Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 116: South Korea Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 117: South Korea Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 118: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 119: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Value, By Application, 2023 (USD Million)
• Figure 120: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, By Value, 2023 (%)
• Figure 121: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Share, By Application, By Value, 2023 (%)
• Figure 122: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market Share, By End User, By Value, 2023 (%)
• Figure 123: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Value, 2020H-2030F (USD Million)
• Figure 124: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Share, By Product Type, 2023 (%)
• Figure 125: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 126: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 127: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 128: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 129: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 130: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 131: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 132: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 133: Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
• Figure 134: Global Impact of Drivers and Restraints
• Figure 135: Market Share of Prominent Companies of Percutaneous Transluminal Angioplasty (PTA), 2023 (%)
• Figure 136: Medtronic PLC Revenues, 2021-2023 (USD Million)
• Figure 137: Medtronic PLC Revenue , By Business Segments, 2023 (%)
• Figure 138: Medtronic PLC Revenue , By Geographic Segments, 2023 (%)
• Figure 139: Terumo Corporation Revenues, 2021-2023 (USD Million)
• Figure 140: Terumo Corporation Revenue , By Business Segments, 2023 (%)
• Figure 141: Terumo Corporation Revenue , By Geographic Segments, 2023 (%)
• Figure 142: Cardinal Health Revenue, 2021-2023 (USD Billion)
• Figure 143: Cardinal Health Business Segment Revenue, 2023 (%)
• Figure 144: Cardinal Health Geographical Segment Revenue, 2023 (%)
• Figure 145: Boston Scientific Revenues, 2021-2023 (USD Million)
• Figure 146: Boston Scientific Revenues, By Geographic Segments, 2023 (%)
• Figure 147: Boston Scientific Companies Revenue , By Business Segments, 2023 (%)
• Figure 148: Teleflex Incorporated Revenues, 2021-2023 (USD Million)
• Figure 149: Teleflex Incorporated Revenues, By Geographic Segments, 2023 (%)
• Figure 150: Teleflex Incorporated Revenue , By Business Segments, 2023 (%)
• Figure 151: Johnson & Johnson Revenues, 2021-2023 (USD Billion)
• Figure 152: Johnson & Johnson Revenues, By Geographic Segments, 2023 (%)
• Figure 153: Johnson & Johnson Revenue , By Business Segments, 2023 (%)
• Figure 154: Abbott Laboratories Revenues, 2021-2023 (USD Million)
• Figure 155: Abbott Laboratories Revenues, By Geographic Segments, 2023 (%)
• Figure 156: Abbott Laboratories Revenue , By Business Segments, 2023 (%)
• Figure 157: Stryker Corporation Revenues, 2021-2023 (USD Million)
• Figure 158: Stryker Corporation Revenue , By Business Segments, 2023 (%)
• Figure 159: Stryker Corporation Revenue , By Geographic Segments, 2023 (%)
• Figure 160: Becton Dickinson and Co Revenues, 2021-2023 (USD Billion)
• Figure 161: Becton Dickinson and Co Revenue , Product Sales By Business Segments, 2023 (%)
• Figure 162: Becton Dickinson and Co Revenue , By Geographical Segments, 2023 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A3: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A4: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A5: United States Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A6: United States Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A7: United States Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A8: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A9: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A10: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A11: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A12: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A13: Canada Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A14: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A15: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A16: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A17: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A18: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A19: Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A20: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A21: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A22: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A23: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A24: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A25: United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A26: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A27: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A28: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A29: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A30: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A31: Germany Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A32: France Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A33: France Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A34: France Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A35: France Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A36: France Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A37: France Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A38: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A39: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A40: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A41: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A42: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A43: Spain Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A44: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A45: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A46: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million

Table A47: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A48: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A49: Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A50: China Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A51: China Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A52: China Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A53: China Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A54: China Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A55: China Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A56: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A57: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A58: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A59: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A60: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A61: Japan Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A62: India Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A63: India Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A64: India Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A65: India Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A66: India Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A67: India Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A68: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A69: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A70: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A71: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A72: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A73: South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A74: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2020-2023 (USD Million)

Table A75: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type, By Value, 2024-2030 (USD Million)

Table A76: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2020-2023 (USD Million)

Table A77: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application, By Value, 2024-2030 (USD Million)

Table A78: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2020-2023 (USD Million)

Table A79: Rest of Asia-Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User, By Value, 2024-2030 (USD Million)

Table A80: Medtronic PLC Key Company Financials, 2021-2023

Table A81: Terumo Corporation Key Company Financials, 2021-2023

Table A82: Cardinal Health Key Company Financials, 2021-2023

Table A83: Boston Scientific Key Financials, 2021-2023

Table A84: Teleflex Incorporated Key Financials, 2021-2022

Table A85: Johnson & Johnson Key Financials, 2021-2023

Table A86: Abbott Laboratories Key Financials, 2021-2023

Table A87: Stryker Corporation Key Company Financials, 2021-2023

Table A88: Becton Dickinson Key Company Financials, 2021-2023

Executive Summary

Azoth Analytics has released a research report titled "Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition)" which provides a complete analysis of the Global Percutaneous Transluminal Angioplasty (PTA) industry in terms of market segmentation by Product Type (Balloon Catheters, Stents, Guidewires Others), by Application (Coronary Artery Disease, Peripheral Artery Disease), by End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom, Germany, France, Spain, China, India, Japan, South Korea). The Global Percutaneous Transluminal Angioplasty (PTA) market showcased growth at a CAGR of 10.25% during 2020-2023. The market was valued at USD 2.92 Billion in 2023 which is expected to reach USD 6.95 Billion in 2030. The global percutaneous transluminal angioplasty (PTA) market is driven by the rising prevalence of cardiovascular diseases, technological advancements, an aging population, growing awareness, improved healthcare infrastructure, favorable reimbursement policies, increased adoption of minimally invasive procedures, rising healthcare expenditure, medical tourism, and strategic industry collaboration.

According to World Heart Federation, more than half a billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021- close to a third of all deaths globally and an overall increase on the estimated 121 million CVD deaths. Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and cardiac arrhythmias, continue to be leading causes of morbidity and mortality globally. This surge in cardiovascular conditions creates a greater demand for effective, minimally invasive treatment options like PTA, which restore blood flow in blocked or narrowed arteries without the need for major surgery.

The growing awareness of minimally invasive options has led to increased patient demand for procedures like PTA. Patients often prefer minimally invasive techniques due to their perceived advantages, including reduced pain, scarring, and recovery time. Also, Healthcare providers are increasingly adopting minimally invasive techniques like PTA as standard practice in the management of CVDs. Advances in medical technology and techniques have made PTA procedures safer, more effective, and easier to perform, leading to greater acceptance among clinicians.

Drug-coated balloon (DCB) technology represents a significant advancement in balloon catheters for percutaneous transluminal angioplasty (PTA). These balloons are coated with anti-proliferative drugs, such as paclitaxel or sirolimus, which are released locally into the arterial wall during inflation. This targeted drug delivery helps to inhibit smooth muscle cell proliferation and reduce neointimal hyperplasia, thereby improving long-term vessel patency compared to traditional uncoated balloons. DCBs have demonstrated efficacy in reducing restenosis rates and the need for repeat interventions, particularly in complex lesions or small vessels. This technology offers a promising approach to improving the outcomes of PTA procedures by addressing one of the primary challenges associated with angioplasty-restenosis.

Advanced imaging modalities, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), play a crucial role in enhancing the treatment of peripheral artery disease (PAD). IVUS and OCT provide high-resolution imaging of peripheral arteries, allowing for precise lesion assessment and treatment planning. By offering real-time guidance during PTA procedures, IVUS and OCT help optimize balloon sizing, stent placement, and post-dilation techniques, leading to improved procedural outcomes and reduced rates of complications in PAD patients. This feature represents a significant advancement in the treatment of PAD, providing clinicians with invaluable tools to enhance procedural precision and patient care in the global PTA market.

Advancements in precision medicine and personalized therapies aim to tailor PTA treatments to individual patient characteristics, including genetic predispositions, disease phenotypes, and response profiles. Biomarker-guided interventions, patient-specific treatment algorithms, and targeted drug delivery systems offer opportunities to optimize treatment outcomes and minimize adverse events in PTA procedures.

Scope of the Report:

• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Value (USD Million).
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Epidemiology.
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom, Germany, France, Spain, China, India, Japan, South Korea).
• The report presents the analysis of Percutaneous Transluminal Angioplasty (PTA) Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Product Type (Balloon Catheters, Stents, Guidewires, Others).
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Application (Coronary Artery Disease, Peripheral Artery Disease).
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by product type, by application, & by end user.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Medtronic PLC, Terumo Corporation, Cardinal Health, Boston Scientific, Teleflex Incorporated, Johnson & Johnson, Abbott Laboratories, Stryker Corporation, Becton Dickinson and Co, and Cook Group Inc.

Table of Contents

1. Market Background

• 1.1 Scope and Product Outlook
• 1.2 Executive Summary
• 1.3 Research Methodology

2. Strategic Recommendations

• 2.1 Explore the availability of combination therapies
• 2.2 Expand the prevalence of low cost therapies in developing countries

3. Global Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

• 3.1 Impact Analysis of Macro Economic Factors on Global Percutaneous Transluminal Angioplasty (PTA) Market
• 3.2 Epidemiology: Global Chronic Disease Prevalence
• 3.3 Epidemiology: Global Chronic Disease Incidence
• 3.4 Global Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
• 3.5 Degree of Impact of Covid-19 on Percutaneous Transluminal Angioplasty (PTA) Market
• 3.6 Global Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
  • 3.6.1 Global Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
  • 3.6.2 Global Percutaneous Transluminal Angioplasty (PTA) Market Attractiveness Index, By Product Type Overview
  • 3.6.3 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • 3.6.4 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • 3.6.5 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • 3.6.6 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• 3.7 Global Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
  • 3.7.1 Global Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
  • 3.7.2 Global Percutaneous Transluminal Angioplasty (PTA) Market Attractiveness Index, By Application Overview
  • 3.7.3 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 3.7.4 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• 3.8 Global Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
  • 3.8.1 Global Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
  • 3.8.2 Global Percutaneous Transluminal Angioplasty (PTA) Market Attractiveness Index, By End User Overview
  • 3.8.3 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • 3.8.4 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • 3.8.5 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)

4. Global Percutaneous Transluminal Angioplasty (PTA) Market, Region Analysis

• 4.1 Regional Coverage of the Study
• 4.2 Regional Snapshot

5. Americas Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

• 5.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
• 5.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
• 5.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
• 5.4 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
• 5.5 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
  • 5.5.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
  • 5.5.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • 5.5.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • 5.5.4 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • 5.5.5 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• 5.6 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
  • 5.6.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
  • 5.6.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 5.6.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• 5.7 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
  • 5.7.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
  • 5.7.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • 5.7.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • 5.7.4 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
• 5.8 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Country
  • 5.8.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Country Overview
  • 5.8.2 United States Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 5.8.2.1 United States Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 5.8.2.2 United States Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 5.8.2.3 United States Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 5.8.3 Canada Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 5.8.3.1 Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 5.8.3.2 Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 5.8.3.3 Canada Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 5.8.4 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 5.8.4.1 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 5.8.4.2 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 5.8.4.3 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User

6. Europe Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

• 6.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
• 6.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
• 6.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
• 6.4 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
• 6.5 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
  • 6.5.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
  • 6.5.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • 6.5.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • 6.5.4 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • 6.5.5 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• 6.6 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
  • 6.6.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
  • 6.6.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 6.6.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• 6.7 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
  • 6.7.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
  • 6.7.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • 6.7.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • 6.7.4 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
• 6.8 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Country
  • 6.8.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Country Overview
  • 6.8.2 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 6.8.2.1 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 6.8.2.2 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 6.8.2.3 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 6.8.3 Germany Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 6.8.3.1 Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 6.8.3.2 Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 6.8.3.3 Germany Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 6.8.4 France Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 6.8.4.1 France Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 6.8.4.2 France Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 6.8.4.3 France Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 6.8.5 Spain Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 6.8.5.1 Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 6.8.5.2 Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 6.8.5.3 Spain Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 6.8.6 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 6.8.6.1 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 6.8.6.2 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 6.8.6.3 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User

7. Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

• 7.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
• 7.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
• 7.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
• 7.4 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
• 7.5 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
  • 7.5.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
  • 7.5.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • 7.5.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • 7.5.4 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • 7.5.5 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• 7.6 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
  • 7.6.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
  • 7.6.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 7.6.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• 7.7 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
  • 7.7.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
  • 7.7.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • 7.7.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • 7.7.4 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
• 7.8 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Country
  • 7.8.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Country Overview
  • 7.8.2 China Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 7.8.2.1 China Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 7.8.2.2 China Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 7.8.2.3 China Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 7.8.3 Japan Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 7.8.3.1 Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 7.8.3.2 Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 7.8.3.3 Japan Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 7.8.4 India Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 7.8.4.1 India Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 7.8.4.2 India Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 7.8.4.3 India Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 7.8.5 South Korea Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 7.8.5.1 South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 7.8.5.2 South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 7.8.5.3 South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By End User
  • 7.8.6 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    • 7.8.6.1 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
    • 7.8.6.2 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application
    • 7.8.6.3 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User

8. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

• 8.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
• 8.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
• 8.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
• 8.4 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
• 8.5 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
  • 8.5.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
  • 8.5.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
  • 8.5.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
  • 8.5.4 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
  • 8.5.5 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
• 8.6 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
  • 8.6.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
  • 8.6.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
  • 8.6.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
• 8.7 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
  • 8.7.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
  • 8.7.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
  • 8.7.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
  • 8.7.4 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)

9. Market Dynamics

• 9.1 Impact assessment of Market Dynamics on Global Percutaneous Transluminal Angioplasty (PTA) Market
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Trends

10. Industry Ecosystem Analysis

• 10.1 Porter Analysis

11. Competitive Positioning

• 11.1 Companies' Product Positioning
• 11.2 Market Share of Leading Companies
• 11.3 Company Profiling
  • 11.3.1 Medtronic PLC
  • 11.3.2 Terumo Corporation
  • 11.3.3 Cardinal Health, Inc
  • 11.3.4 Boston Scientific
  • 11.3.5 Teleflex Incorporated
  • 11.3.6 Johnson & Johnson
  • 11.3.7 Abbott Laboratories
  • 11.3.8 Stryker Corporation
  • 11.3.9 Becton Dickinson and Co
  • 11.3.10 Cook Group Inc.

12. About Us and Disclaimer